Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis
AssigneeAlcon Inc.
InventorElias Humberto Hermida Ochoa
Life of this patent
Estimating the term…
Abstract
This invention is related to the use of the composition formed by sodium hyaluronate and sodium chondroitin sulfate for the treatment of chondral lesions in osteoarthritis, and to the use of such composition in the manufacture of a product for such treatment.
Claims20
A therapeutic method for the treatment of a joint exhibiting degeneration of articular cartilage comprising the intraarticular administation to said joint of a viscous composition comprising a therapeutically effective amount of a mixture of chondroitin sulfate and hyaluronic acid or pharmaceutically acceptable salts thereof.
The use of stable, viscous, buffered aqueous solution which comprises a mixture of chondroitin sulfate at a, concentration of about 0.1 to 50% by weight and sodium hyaluronate at a concentration of about 0.1 to 50% by weight in the manufacture of a product for the intraarticular treatment of chondromalacia and/or osteoarthritis.
A method of repairing or regenerating cartilage in a mammalian joint characterized by cartilage disease or trauma, comprising the intraarticular instillation of a mixture of chondroitin sulfate and hyaluronic acid or pharmaceutically acceptable salts thereof.
Use of a mixture of chondroitin sulfate and hyaluronic acid or pharmaceutically acceptable salts thereof in the manufacture of a product for repairing or regenerating cartilage in a mammalian joint characterized by cartilage disease or trauma.
Dependencies are inferred from the claim text.